Holen Sie sich die Stockscreener-App
160.46
2.50%
3.91
Handel nachbörslich:
160.34
-0.12
-0.07%
Schlusskurs vom Vortag:
$156.55
Offen:
$157.51
24-Stunden-Volumen:
9.18M
Relative Volume:
1.01
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.85%
1M Leistung:
+25.59%
6M Leistung:
+32.04%
1J Leistung:
+89.24%
1-Tages-Spanne:
$156.48
$160.82
1-Wochen-Bereich:
$151.20
$160.82
52-Wochen-Spanne:
$83.02
$160.82
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
160.46 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
June's Top ETFs: Biotech & China Semiconductors Surge - ETF Database
XBI Ignored The Market’s Downturn - Trefis
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Arcus Biosciences, Inc. Stocks - TradingView
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
ETFs Investing in Viking Therapeutics, Inc. Stocks - TradingView
XBI Ignored The Market's Downturn - Trefis
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In. - Barron's
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech - AOL.com
SELLAS Life Sciences (NASDAQ:SLS) rises as short interest builds, company files change-control ahead of AML update - TechStock²
Biotech ETFs put up strong show in 1H 2026: More gains ahead? - MSN
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Healthcare: Pockets of Alpha - Investing.com
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)? - MSN
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Biotech stocks are losing momentum despite rising M&A activity - MSN
This Biotech Could Become a ‘Sleeper’ Hit - TheStreet Pro
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - AOL.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
State Street Announces Splits for 10 Industry ETFs - Yahoo Finance
XBI: A "Hidden" ETF Up +70% In 1 Year. (NYSEARCA:XBI) - Seeking Alpha
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF - Benzinga
MacroGenics Inc (MGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Praxis Precision Medicines Inc (PRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Upstream Bio Inc (UPB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Iovance Biotherapeutics Inc (IOVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Day One Biopharmaceuticals Inc (DAWN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novavax Inc (NVAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Replimune Group Inc (REPL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amicus Therapeutics Inc (FOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roivant Sciences Ltd (ROIV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cidara Therapeutics Inc (CDTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viridian Therapeutics Inc (VRDN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AnaptysBio Inc (ANAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcus Biosciences Inc (RCUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Grail Inc (GRAL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Syndax Pharmaceuticals Inc (SNDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ARS Pharmaceuticals Inc (SPRY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kalvista Pharmaceuticals Inc (KALV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oric Pharmaceuticals Inc (ORIC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precigen Inc (PGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viking Therapeutics Inc (VKTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):